Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)
Israel · Delayed Price · Currency is ILS · Price in ILA 250.00
-90.90 (-26.66%)
Aug 7, 2026, 1:44 PM IDT
TLV:TKUN Revenue
In the year 2025, Tikun Olam-Cannbit Pharmaceuticals had annual revenue of 9.10M ILS, down -73.96%. Tikun Olam-Cannbit Pharmaceuticals had revenue of 14.10M in the half year ending December 31, 2024, a decrease of -49.90%.
Revenue
9.10M
Revenue Growth
-79.02%
P/S Ratio
0.20
Revenue / Employee
n/a
Employees
4
Market Cap
1.84M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.10M | -25.85M | -73.96% |
| Dec 31, 2024 | 34.95M | -9.28M | -20.97% |
| Dec 31, 2023 | 44.23M | -5.07M | -10.28% |
| Dec 31, 2022 | 49.30M | 12.27M | 33.13% |
| Dec 31, 2021 | 37.03M | 15.37M | 70.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 51.58B |
| Kamada | 573.62M |
| Rekah Pharmaceutical Industry | 304.15M |
| InterCure | 270.20M |
| Seach Medical Group | 157.16M |
| Together Pharma | 109.63M |
| Nextage Therapeutics | 243.00K |